Altium Capital Management LLC 13D/13G Filings for BriaCell Therapeutics Corp. (BCTX)

Altium Capital Management LLC 13D and 13G filings for BriaCell Therapeutics Corp.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-11
8:39 pm
Purchase
2021-12-3113GBriaCell Therapeutics Corp.
BCTX
Altium Capital Management LLC6,000
4.700%
2,667increase
(+80.00%)
Filing
2021-03-08
4:16 pm
Purchase
2021-02-2413GBriaCell Therapeutics Corp.
BCTX
Altium Capital Management LLC3,333
8.900%
3,333increase
(New Position)
Filing